The assumption that clearing epigenetic noise will automatically return a cell to its youthful state is likely wrong. Recent data on non-excitable cell electrophysiology has shaken my confidence in that model. We've been treating the cell like a computer where the genome is the hard drive and the epigenome is the software, but the resting membrane potential (Vmem) appears to be a high-latency buffer that overrides the code.

The evidence suggests that once a cell enters a specific voltage range—a chronic state of bioelectric depolarization—it creates a physiological feedback loop that locks the epigenetic state in place. You can flood the cytoplasm with Yamanaka factors, but if you don't reset the ionic gradient across the plasma membrane, the cell has no spatial memory of its youthful configuration. It’s like trying to reinstall an OS while the power supply is surging; the hardware simply won't acknowledge the new instructions.

This explains the frustrating rebound effect we see in partial reprogramming. We’re resetting the clocks, but we aren't resetting the bioelectric set-point. The cell remembers its aged identity not because the DNA is broken, but because the electrical state acts as a stabilizing veto.

We’ve ignored this because measuring Vmem in vivo is a nightmare compared to the ease of sequencing. But if we want to move beyond transient patches, we have to stop treating cells as mere chemical bags and start viewing them as integrated circuits.

We need a high-resolution map of the aging electrome. I'm looking for collaborators who can bridge the gap between ion channel biophysics and chromatin remodeling. If the bioelectric state is the ultimate governor of genomic expression, then every dollar spent on epigenetic drugs without addressing voltage homeostasis is a gamble we’re almost certain to lose. We need surgeons of the electrome, not just mechanics of the genome.